The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Role of p38 MAP Kinase Signal Transduction in Solid Tumors
Open accessAbstract
Mitogen-activated protein kinases (MAPKs) mediate a wide variety of cellular behaviors in response to extracellular stimuli. One of the main subgroups, the p38 MAP kinases, has been implicated in a wide range of complex biologic processes, such as cell proliferation, cell differentiation, cell death, cell migration, and invasion. Dysregulation of p38 MAPK levels in patients are associated with advanced stages and short survival in cancer patients (e.g., prostate, breast, bladder, liver, and lung cancer). p38 MAPK plays a dual role as a regulator of cell death, and it can either mediate cell survival or cell death depending not only on the type of stimulus but also in a cell type specific manner. In addition to modulating cell survival, an essential role of p38 MAPK in modulation of cell migration and invasion offers a distinct opportunity to target this pathway with respect to tumor metastasis. The specific function of p38 MAPK appears to depend not only on the cell type but also on the stimuli and/or the isoform that is activated. p38 MAPK signaling pathway is activated in response to diverse stimuli and mediates its function by components downstream of p38. Extrapolation of the knowledge gained from laboratory findings is essential to address the clinical significance of p38 MAPK signaling pathways. The goal of this review is to provide an overview on recent progress made in defining the functions of p38 MAPK pathways with respect to solid tumor biology and generate testable hypothesis with respect to the role of p38 MAPK as an attractive target for intervention of solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–255 of 255
Liu, R. Y., Fan, C. L., Liu, G., Olashaw, N., & Zuckerman, K. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001281200 · Cited by 72
Mitogen Activated Protein kinase signal transduction pathways in the prostate
MARONI, P. D., Koul, S., Meacham, R. B., & Koul, H. K. (2004) · Cell Communication and Signaling · doi:10.1186/1478-811x-2-5 · Cited by 70
Self-citationPomérance, M., Quillard, J., Chantoux, F., Young, J., & Blondeau, J. (2006) · The Journal of Pathology · doi:10.1002/path.1975 · Cited by 69
Suarez‐Cuervo, C., Merrell, M. A., Watson, L., Harris, K. W., Rosenthal, E. L., Väänänen, H. K., & Selander, K. S. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-3503-x · Cited by 68
Guan, M., Fousek, K., & Chow, W. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08619.x · Cited by 67
ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion
Chen, L., He, H., Li, H., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.023 · Cited by 67
MacFarlane, M., Cohen, G. M., & Dickens, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480093 · Cited by 67
A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-β
Ono, K., Ohtomo, T., Ninomiya‐Tsuji, J., & Tsuchiya, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01207-5 · Cited by 66
Davidson, B., Konstantinovsky, S., Nielsen, S. M., Dong, H. P., Berner, A., Vyberg, M., & Reich, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0183 · Cited by 66
Tuohimaa, P., Lyakhovich, A., Aksenov, N., Pennanen, P. T., Syvälä, H., Lou, Y., Ahonen, M. H., Hasan, T., Pasanen, P., Bläuer, M., et al. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00141-2 · Cited by 62
Frazier, W. J., Xue, J., Luce, W. A., & Liu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050071 · Cited by 61
Dreissigacker, U., Mueller, M. S., Unger, M., Siegert, P., Genze, F., Gierschik, P., & Giehl, K. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.09.004 · Cited by 61
Regulation of anoikis by Cdc42 and Rac1
Cheng, T., Symons, M. H., & Jou, T. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.02.002 · Cited by 60
Bracke, M. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)86973-8 · Cited by 60
Park, J. I., Lee, M. G., Cho, K. H., Park, B. J., Chae, K. S., Byun, D.-S., Ryu, B. K., Park, Y. K., & Chi, S.-G. (2004) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2003.12.015 · Cited by 60
Sayama, K., Hanakawa, Y., Nagai, H., Shirakata, Y., Dai, X., Hirakawa, S., Tokumaru, S., Tohyama, M., Yang, L., Sato, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601065200 · Cited by 59
Heat shock protein-90, IL-6 and IL-10 in bladder cancer.
Cardillo, M. R., Sale, P., & Silverio, F. D. (2001) · PubMed · Cited by 58
Vassalli, G., Milano, G., & Moccetti, T. (2012) · Journal of Transplantation · doi:10.1155/2012/928954 · Cited by 57
Mitogen-activated protein kinases and apoptosis in PIN
Magi‐Galluzzi, C., Montironi, R., Cangi, M. G., Wishnow, K., & Loda, M. F. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050184 · Cited by 56
Seufferlein, T. T. W., Seckl, M. J., Schwarz, E., Beil, M., von Wichert, G., Baust, H., Lührs, H., Schmid, R. M., & Adler, G. (2002) · British Journal of Cancer · doi:10.1038/sj....bjc.6600186 · Cited by 56
Shan, X., Hu, A., Veler, H., Fatma, S., Grunstein, J. S., Chuang, S., & GRUNSTEIN, M. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00056.2006 · Cited by 55
Horn, G., Gaziel, A., Wreschner, D. H., Smorodinsky, N. I., & Ehrlich, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.02.011 · Cited by 54
Lin, Z., Crockett, D. K., Jenson, S. D., Lim, M. S., & Elenitoba‐Johnson, K. S. J. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400008-mcp200 · Cited by 53
Skjøth, I. H. E., & Issinger, O. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.1.217 · Cited by 52
Zhang, Y., Neo, S. Y., Han, J., Yaw, L. P., & Lin, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2851 · Cited by 52
Sengupta, N., Siddiqui, E. J., & Mumtaz, F. (2004) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400412400520 · Cited by 51
Denkert, C., Siegert, A., Leclere, A., Turzynski, A., & Hauptmann, S. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1013857325012 · Cited by 50
Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells
Koul (2009) · International Journal of Oncology · doi:10.3892/ijo_00000285 · Cited by 49
P38 MAPK protects against TNF-α-provoked apoptosis in LNCaP prostatic cancer cells
Ricote, M., García‐Tuñón, I., Fraile, B., Fernández, C., Aller, P., Paniagua, R., & Royuela, M. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0086-9 · Cited by 48
Lawson, S. K., Dobrikova, E. Y., Shveygert, M., & Gromeier, M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00695-12 · Cited by 47
Inhibitors of serine/threonine kinases
Lee, J. C., & Adams, J. L. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80108-1 · Cited by 46
p38 Mitogen-Activated Protein Kinase and Hematologic Malignancies
Feng, Y., Wen, J., & Chang, C.-C. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.11.1850 · Cited by 46
Park, J. S., Carter, S., Reardon, D. B., Schmidt‐Ullrich, R., Dent, P., & Fisher, P. B. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.12.4231 · Cited by 46
Cronauer, M. V., Schulz, W. A., Burchardt, T., Anastasiadis, A. G., TAILLE, A. D. L., Ackermann, R., & Burchardt, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1095 · Cited by 45
Mehta, P. B., Robson, C. N., Neal, D. E., & Leung, H. Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204688 · Cited by 45
A Subtle Change in p38 MAPK Activity is Sufficient to Suppress In Vivo Tumorigenesis
Timofeev, O. N., Lee, T. Y., & Bulavin, D. V. (2004) · Cell Cycle · doi:10.4161/cc.4.1.1342 · Cited by 44
Phosphatidylinositol 3-Kinase Is a Key Regulator of Early Phase Differentiation in Keratinocytes
Sayama, K., Yamasaki, K., Hanakawa, Y., Shirakata, Y., Tokumaru, S., Ijuin, T., Takenawa, T., & Hashimoto, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112423200 · Cited by 44
Expression of Fas-related genes in human hepatocellular carcinomas
Shin, E., Shin, J., Park, J. H., Kim, J.-J., Kim, H., & Kim, S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00251-1 · Cited by 43
Aaltonen, V., Boström, P. J., Söderström, K., Hirvonen, O., Tuukkanen, J., Nurmi, M. J., Laato, M. K., & Peltonen, J. T. K. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65322-9 · Cited by 42
Xiao, D., Qu, X., & Weber, H. C. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00197-0 · Cited by 42
Urinary bladder lesions induced by persistent chronic low‐dose ionizing radiation
Am, R., Morimura, K., Wanibuchi, H., Wei, M., Zaparin, W. K., Vinnichenko, W. I., Kakehashi, A., Vozianov, A. F., & Fukushima, S. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01441.x · Cited by 42
Inhibitors of Vascular Endothelial Growth Factor in Cancer
Pourgholami, M. H., & Morris, D. L. (2008) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152508785909528 · Cited by 41
Lee, T.-J., Sartor, O. A., Luftig, R. B., & Koochekpour, S. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-31 · Cited by 41
Wu, J., Suzuki, H., Akhand, A. A., Zhou, Y., Hossain, K., & Nakashima, I. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00278-9 · Cited by 38
ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells
Nguyen, T., Mustafa, F. B., Pervaiz, S., Ng, F., & Lim, L. H. K. (2008) · International Journal of Oncology · doi:10.3892/ijo.33.1.81 · Cited by 37
Huynh, H. T. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.6.1297 · Cited by 37
Yong, H., Hwang, J.-S., Son, H., Park, H.-I., Oh, E., Kim, H.-H., Kim, D. K., Choi, W. S., Lee, B., Kim, H.-R. C., et al. (2011) · Neoplasia · doi:10.1593/neo.101088 · Cited by 35
Lin, J., Chang, S., Hsieh, D.-S., Lee, C.-F., & Yü, D. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000176476.14572.39 · Cited by 34
Murillo, H., Schmidt, L. J., & Tindall, D. J. (2001) · PubMed · Cited by 34
Hsu, Y.-C., & Ip, M. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.015 · Cited by 33
Rust, W. L., Kingsley, K., Petnicki, T., Padmanabhan, S., Carper, S. W., & Plopper, G. E. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0130 · Cited by 32
Cho, S., Ahn, N., Jung, J., Yang, S., Park, J., Lee, Y., Jo, E.-H., Hwang, J., Lii, J., & Kang, K. (2005) · European Journal of Cancer Prevention · doi:10.1097/01.cej.0000195704.05246.fc · Cited by 26
Fuchs, H. J., Debs, R. J., Patton, J. S., et al. (1990) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(90)90010-s · Cited by 15
Han, Y., Zeng, X., Wang, R. T., et al. (2007) · PubMed · Cited by 14
Cell type-specific analyses for identifying prostate cancer biomarkers
Nelson, P. S., & Montgomery, B. (2006) · Current Urology Reports · doi:10.1007/s11934-006-0039-4 · Cited by 1
Cited by
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Photodynamic Therapy—Current Limitations and Novel Approaches
Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.691697 · Cited by 599
Biomedical Implications of Heavy Metals Induced Imbalances in Redox Systems
Sharma, B., Singh, S., & Siddiqi, N. J. (2014) · BioMed Research International · doi:10.1155/2014/640754 · Cited by 419
RetractedTargeting RTK Signaling Pathways in Cancer
Regad, T. (2015) · Cancers · doi:10.3390/cancers7030860 · Cited by 380
Targeted protein degradation: A promise for undruggable proteins
Samarasinghe, K. T. G., & Crews, C. M. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.04.011 · Cited by 271
Metadata
- Authors
- Koul, H. K., Pal, M., & Koul, S.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2013-09-01
- Volume
- 4
- Issue
- 9-10
- Pages
- 342-359
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2164575467
- Cited by
- 484
- References
- 255
- FWCI
- 14.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.